Xolair

omalizumab


XOLAIR®


Consumer Medicine Information (CMI) summary

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.


1. Why am I using XOLAIR?

XOLAIR contains the active ingredient omalizumab. XOLAIR is used to treat allergic asthma and chronic rhinosinusitis with nasal polyps (nasal polyps).For more information, see Section 1. Why am I using XOLAIR? in the full CMI.

2. What should I know before I use XOLAIR?

Do not use if you have ever had an allergic reaction to omalizumab or any of the ingredients listed at the end of the CMI.

Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use XOLAIR? in the full CMI.

3. What if I am taking other medicines?

Some medicines may interfere with XOLAIR and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

4. How do I use XOLAIR?

  • Your healthcare provider will prescribe the dose of XOLAIR that is right for you. Use XOLAIR exactly as prescribed.
  • Do not try to inject XOLAIR yourself until you or your caregiver has been shown how by your healthcare provider.
  • If you have forgotten to inject a dose of XOLAIR, do not take a double dose to make up for the dose you missed.

More instructions can be found in Section 4. How do I use XOLAIR? in the full CMI.

5. What should I know while using XOLAIR?

Things you should do

  • Discontinue treatment and tell your doctor or pharmacist immediately if you get any signs or symptoms of a potentially serious infection or an allergic reaction during treatment with XOLAIR.
  • Tell your doctor you are taking XOLAIR before a vaccination as live vaccines are not suitable for you.

Things you should not do

  • Do not stop taking your medicine or change dosage without checking with your doctor first.
  • Do not use this medicine if the liquid contains easily visible particles, is cloudy or is distinctly brown.
  • Do not use if the outer box or blister seals are broken, or if it has been dropped with the cap removed.

Driving or using machines

  • Be careful before you drive or use any machines or tools until you know how XOLAIR affects you.

Looking after your medicine

  • Keep it in a refrigerator at 2°C to 8°C. Do not freeze it.
  • Allow the syringe to reach room temperature (25°C) before injection. If necessary, XOLAIR may be returned to the refrigerator for later use. The total time that the syringe is kept at room temperature must not exceed 48 hours.

For more information, see Section 5. What should I know while using XOLAIR? in the full CMI.

6. Are there any side effects?

All medicines can have side effects although not everybody gets them. The most common side effects of XOLAIR include fever, injection site reactions, abdominal pain, swelling, itching, headaches, cold symptoms and upper respiratory infections. XOLAIR may cause serious allergic reactions. Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking XOLAIR. For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.

XOLAIR® (zo-lair)

Active ingredient(s): omalizumab


Consumer Medicine Information (CMI)

This leaflet provides important information about using XOLAIR. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using XOLAIR.

Where to find information in this leaflet:

1. Why am I using XOLAIR?

2. What should I know before I use XOLAIR?

3. What if I am taking other medicines?

4. How do I use XOLAIR?

5. What should I know while using XOLAIR?

6. Are there any side effects?

7. Product details

8. Instructions for use of XOLAIR pre-filled syringe (pre-filled syringe with 26-gauge staked needle)

9. Instructions for use of XOLAIR pre-filled syringe (pre-filled syringe with 27-gauge staked needle)

10. Instructions for use of XOLAIR pre-filled pen

11. Information for the Healthcare Professional: XOLAIR powder vial & diluent

1. Why am I using XOLAIR?

XOLAIR contains the active ingredient omalizumab. XOLAIR is a monoclonal antibody. Monoclonal antibodies are proteins that recognise and attach specifically to certain proteins in the body. XOLAIR works by blocking a substance produced by the body called immunoglobulin E (or IgE). IgE contributes to a type of inflammation that is involved in causing symptoms of conditions such as:

  • allergic asthma
  • chronic rhinosinusitis with nasal polyps (nasal polyps)
  • chronic spontaneous urticaria (hives)

Allergic asthma

XOLAIR is used to prevent or relieve the symptoms of allergic asthma in people who are already using preventer puffers containing steroids.

Asthma is a disease where the lining of the lungs becomes inflamed (red and swollen), making it difficult to breathe. This may be due to a reaction to house dust mites, smoke or other irritants.

XOLAIR can be used in adults and in children aged 6 years or over in allergic asthma.

Chronic rhinosinusitis with nasal polyps (nasal polyps)

XOLAIR is used to treat a condition called 'chronic rhinosinusitis with nasal polyps' (nasal polyps) in people whose severe disease is not well controlled with their current nasal polyps medicines.

XOLAIR helps reduce the size of the polyps and improves symptoms caused by nasal polyps including nasal congestion, loss of sense of smell, post-nasal drip and runny nose.

This medicine can be used in adults aged 18 years and over in nasal polyps. Its use in children and adolescents below 18 years of age with nasal polyps has not been studied.

Chronic spontaneous urticaria (hives)

XOLAIR is used to treat a condition called 'chronic spontaneous urticaria' (hives) in adults and adolescents (12 years of age and older) whose symptoms are not well controlled by antihistamines. Elderly patients are given the same dosage as younger adults.

2. What should I know before I use XOLAIR?

Warnings

Do not use XOLAIR if:

  • you are allergic to omalizumab, or any of the ingredients listed at the end of this leaflet. Always check the ingredients to make sure you can use this medicine. Some of the symptoms of an allergic reaction may include:
    • shortness of breath, wheezing or difficulty breathing or swallowing
    • swelling of the face, lips, tongue or other parts of the body
    • rash, itching or hives on the skin

If you think you may be allergic, ask your doctor for advice before using XOLAIR.

  • Do not take XOLAIR if you have an active infection which your doctor thinks is important.
  • Do not take XOLAIR if there are visible signs of deterioration. If it has expired or is damaged, return it to your pharmacist for disposal.

Check with your doctor if you are not sure whether you should start taking this medicine or you:

  • have kidney or liver problems
  • have autoimmune disease
  • live in a region where parasite infections are frequent, XOLAIR may weaken your resistance to such infections
  • had a previous severe allergic reaction (anaphylaxis) resulting, for example, from medicine, an insect bite or food
  • had an allergic reaction to latex
  • have a low platelet count (thrombocytopenia)

You should not use XOLAIR to prevent or treat other allergy-type conditions:

  • sudden allergic reactions
  • hyperimmunoglobulin E syndrome (an inherited immunodeficient disorder)
  • aspergillosis (a fungus-related lung disease)
  • food allergy, allergic skin rash or hay fever.

You should not use XOLAIR to treat acute asthma symptoms, like a sudden asthma attack. You will have been given a separate medicine for this.

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

Check with your doctor if you are pregnant or intend to become pregnant. XOLAIR is not recommended during pregnancy unless the benefits clearly outweigh the potential risks.

Talk to your doctor if you are breastfeeding or intend to breastfeed.

Special populations

  • XOLAIR is not recommended for children under 6 years of age with allergic asthma because it has not been studied sufficiently in this age group.
  • XOLAIR is not recommended for children and adolescents under 18 years of age with nasal polyps because it has not been studied in this age group.
  • XOLAIR is not recommended for children under 12 years of age with chronic spontaneous urticaria because it has not been studied sufficiently in this age group.
  • XOLAIR may be used by people aged 65 years and over.

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

XOLAIR has been used together with inhaled and/or intranasal corticosteroids other common medicines for asthma/or nasal polyps, as well as H1 or H2 antihistamines and LTRAs for chronic spontaneous urticaria.

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect XOLAIR. Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine.

4. How do I use XOLAIR?

How much to give / use

Your doctor will decide how much XOLAIR you need and how often you will need it. This depends on your body weight and the results of a blood test carried out before the start of the treatment to measure the amount of IgE in your blood

  • Allergic asthma and Chronic Rhinosinusitis with Nasal Polyps

You will need 1 to 4 injections at a time. You will need the injections either every two weeks or every four weeks as prescribed by your doctor.

XOLAIR 300 mg pre-filled syringe and all dose strengths of XOLAIR pre-filled pens are not intended for use in children under 12 years of age.

XOLAIR 75 mg pre-filled syringe and XOLAIR 150 mg pre-filled syringe or XOLAIR powder and solvent for solution for injection may be used in children 6 to 11 years of age with allergic asthma.

Keep taking your current asthma and/or nasal polyps medicine during XOLAIR treatment. Do not stop taking any asthma and/or nasal polyps medication without talking to your doctor.

  • Chronic spontaneous urticaria (hives)

You will need 1 or 2 injections at a time every four weeks.

Keep taking your current medicine for hives during XOLAIR treatment. Do not stop taking any medicine without talking to your doctor.

  • Do not exceed the recommended dose.
  • Follow the instructions provided and use XOLAIR until your doctor tells you to stop.

How to give XOLAIR

Follow all directions given to you by your doctor, nurse or pharmacist carefully. They may differ from the information contained in this leaflet.

Always use XOLAIR as your doctor has told you. You should check with your doctor, nurse or pharmacist if you are not sure.

XOLAIR is intended for subcutaneous use. This means that it is injected into the fatty tissue just under the skin.

There are two different ways XOLAIR can be given:

  • pre-filled syringe and pre-filled pen: designed to be administered by patients or carers or healthcare professionals.
  • powder for injection vial with diluent: for use by healthcare professionals only.

You and your doctor should decide if you should inject XOLAIR yourself.

After proper training in subcutaneous injection technique, patients ≥ 12 years old may self-inject XOLAIR or, for all patients ≥ 6 years old, the injection may be given by a caregiver if your doctor determines that it is appropriate.

It is important not to try to inject yourself until you have been trained by your doctor, nurse or pharmacist. A caregiver may also give you your XOLAIR injection after proper training.

If you do not understand the instructions on the label ask your doctor or pharmacist for help.

Choosing the injection sites

The injection sites are where the skin will be pierced to administer the subcutaneous injection.

The recommended site is the front of your thighs. You may also use the lower abdomen, but not the area five centimetres around the navel (belly button). Choose a different site each time you give yourself an injection.

If a caregiver is giving you the injection, the outer upper arms may also be used (Shown in grey in the diagram for illustrative purposes).

Do not inject into areas where the skin is tender, bruised, red or hard. Avoid areas with scars or stretch marks.

For detailed instructions on how to inject XOLAIR, see Instructions for Use at the end of this leaflet:

“Instructions for use of XOLAIR pre-filled syringe (pre-filled syringe with 26-gauge staked needle)"

“Instructions for use of XOLAIR pre-filled syringe (pre-filled syringe with 27-gauge staked needle)"

“Instructions for use of XOLAIR pre-filled pen”

"Information for the Healthcare Professional: XOLAIR powder vial & diluent"

Read the Instructions for Use on how to use XOLAIR all the way through before removing XOLAIR end from the refrigerator. These instructions are to help you to inject correctly.

How long to use XOLAIR

Keep using this medicine for as long as your doctor tells you.

Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.

If you forget to use XOLAIR

If you have missed an appointment to get a XOLAIR injection, contact your doctor and get it as soon as you remember.

If you have forgotten to inject a dose of XOLAIR, inject the next dose as soon as you remember. Then talk to your doctor to discuss when you should inject the next dose.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering to have your medicine, ask your pharmacist for some hints.

Do not take a double dose to make up for the dose you missed.

If you use too much XOLAIR

If you think that you have used too much XOLAIR, you may need urgent medical attention.

You should immediately:

  • phone the Poisons Information Centre

(by calling 13 11 26), or

  • contact your doctor, or
  • go to the Emergency Department at your nearest hospital.

You should do this even if there are no signs of discomfort or poisoning.

5. What should I know while using XOLAIR?

Things you should do

Discontinue treatment and tell your doctor or pharmacist immediately if you get any of these symptoms during treatment with XOLAIR.

Call your doctor straight away if you have:

  • Signs or symptoms of a potentially serious infection. These may include:
    • fever, flu-like symptoms, night sweats
    • feeling tired or short of breath; cough which will not go away
    • warm, red and painful skin, or a painful skin rash with blisters
    • burning when passing urine
  • Signs or symptoms of an allergic reaction. These may include:
    • difficulty breathing or swallowing
    • low blood pressure, which can cause dizziness or light-headedness
    • swelling of the face, lips, mouth or throat
    • severe itching of the skin, with a red rash or raised bumps
  • A specific type of allergic reaction (serum sickness) has also been observed in patients treated with XOLAIR. Signs may include:
    • joint pain
    • stiffness
    • rash
    • fever
    • swollen/enlarged lymph nodes
  • Keep all of your doctor's appointments so that your progress can be checked. Your doctor will do tests from time to time to make sure the medicine is working and to prevent unwanted side effects. Your doctor will decide if and when you may restart the treatment.
  • If you need to be vaccinated, tell your doctor you are taking XOLAIR before you have the vaccination.
  • If you are about to be started on any new medicine, remind your doctor and pharmacist that you are taking XOLAIR.
  • Remind any doctor, dentist or pharmacist you visit that you are using XOLAIR.

Things you should not do

  • Do not stop taking your medicine or change dosage without checking with your doctor first.
  • Never leave the prefilled syringe or prefilled pen lying around where others might tamper with it.
  • Do not open the sealed box until you are ready to use XOLAIR.
  • Do not use this medicine if the liquid contains easily visible particles, is cloudy or is distinctly brown.
  • Do not use the prefilled syringe or prefilled pen if either the seal on the outer box or the seal of the blister are broken. It may not be safe for you to use.
  • Do not shake the prefilled syringe or the prefilled pen.
  • Do not use the pen if it has been dropped with the cap removed.
  • Do not take it to treat any other complaints unless your doctor tells you to.
  • Do not give this medicine to anyone else, even if they have the same condition as you.

Driving or using machines

Be careful before you drive or use any machines or tools until you know how XOLAIR affects you.

No studies on the effects on the ability to drive and use of machines have been performed on XOLAIR.

Looking after your medicine

Keep it in a refrigerator at 2°C to 8°C. Do not freeze it.

Store it in the carton in order to protect it from light. Follow the instructions in the carton on how to take care of your medicine properly.

Prior to use, allow the syringe to reach room temperature (25°C) before injection.

Store it in a cool dry place away from moisture, heat or sunlight; for example, do not store it:

  • in the bathroom or near a sink, or
  • in the car or on window sills.

A locked section of the refrigerator, at least one-and-a-half metres above the ground, is a good place to store XOLAIR.

Keep it where young children cannot reach it.

When to discard your medicine

If necessary, the product may be returned to the refrigerator for later use. The total time that the syringe is kept at room temperature must not exceed 48 hours.

Discard any unused product.

Dispose of the used XOLAIR prefilled syringe or prefilled pen immediately after use in a sharps container. The XOLAIR prefilled syringe or prefilled pen should never be re-used.

Getting rid of any unwanted medicine

If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not use this medicine after the expiry date.

6. Are there any side effects?

All medicines can have side effects although not everybody gets them. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking XOLAIR.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

Less serious side effects

Less serious side effects

What to do

  • bruising, redness or pain at the injection site
  • mild skin rash
  • headache
  • tiredness
  • hair loss
  • joint swelling
  • fever (very common in children)
  • sore throat and blocked nose (nasopharyngitis)
  • feeling of pressure or pain in the cheeks and forehead (sinusitis and sinus headache)
  • upper respiratory tract infection, such as inflammation of the pharynx and common cold
  • burning sensation or pain when passing urine and having to urinate frequently (possible symptom of an urinary tract infection)
  • pain in upper or lower limbs (arms and/or legs)
  • pain in the upper part of the abdomen
  • pain in muscles and/or bones and/or joints (musculoskeletal pain, myalgia, arthralgia)

Speak to your doctor if you have any of these less serious side effects and they worry you.

Serious side effects

Serious side effects

What to do

Allergy related

  • anaphylactic shock, where signs may include: swelling of the throat and mouth, difficulty breathing, lightheadedness, confusion, blue skin or lips, collapsing and losing consciousness
  • serum sickness, where signs may include joint pain, stiffness, rash, fever, swollen/enlarged lymph nodes

Blood related

  • abnormal bleeding or bruising

General (Churg-Strauss syndrome)

  • pain, numbness or tingling in the arms and legs, lumps or raised patches in the skin, weakness and fatigue, loss of appetite, and weight loss

Call your doctor straight away, or go straight to the Emergency Department at your nearest hospital if you notice any of these serious side effects.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Other side effects not listed here may occur in some people.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

This medicine is only available with a doctor's prescription.

What XOLAIR contains

Active ingredient

omalizumab

Other ingredients

Solution for injection in prefilled syringe and prefilled pen:

  • arginine hydrochloride
  • histidine
  • histidine hydrochloride monohydrate
  • polysorbate 20
  • water for injections

Vial powder for injection:

  • sucrose
  • histidine
  • histidine hydrochloride monohydrate
  • polysorbate 20

Potential allergens

Sucrose (powder for injection)

Do not take this medicine if you are allergic to any of these ingredients.

What XOLAIR looks like

XOLAIR solution for injection in pre-filled syringe and pre-filled pen is a clear liquid. Its colour may vary from colourless to pale brownish-yellow.

XOLAIR powder for injection vial with diluent is a white to off-white powder that is reconstituted with water for injection.

XOLAIR solution for injection in pre-filled syringe is available in 75 mg/0.5 mL (AUST R 201124), 150 mg/1 mL (AUST R 201126) or 300 mg/3mL (AUST R 429450).

Available as a single packaged and in multipacks containing either 4 or 10 individually packaged pre-filled syringes.

XOLAIR solution for injection in pre-filled autoinjector pen is available in 75 mg/0.5 mL (AUST R 429510), 150 mg/1 mL (AUST R 429511) or 300 mg/3mL (AUST R 429512).

XOLAIR powder for injection vial and diluent is available as a pack containing 1 single-use vial of either 75 mg (AUST R 115399) or 150 mg (AUST R 82744) powder and 1 ampoule of water for injections for use as diluent.

Who distributes XOLAIR

Novartis Pharmaceuticals Australia Pty Limited

ABN 18 004 244 160

54 Waterloo Road

Macquarie Park NSW 2113

Telephone 1 800 671 203

® = Registered Trademark

This leaflet was prepared in September 2024.

(xol300824c_v2 based on PI xol300824i)

8. Instructions for use of XOLAIR pre-filled syringe (pre-filled syringe with 26 gauge staked needle)

Read ALL the way through these instructions before injecting. If your doctor decides that you or a caregiver may be able to give your injections of Xolair at home, you need to be trained by your doctor, nurse or pharmacist before you inject yourself or others. Children (6 to less than 12 years of age) are not expected to inject Xolair themselves, however, if deemed appropriate by their doctor, a caregiver may give them their Xolair injection after proper training. The box contains a Xolair pre-filled syringe individually sealed in a plastic tray.

Xolair pre-filled syringe is available in two strengths, 75 mg and 150 mg. You may receive one or both strengths from the pharmacy.

Your Xolair 75 mg pre-filled syringe (pre-filled syringe with 26-gauge staked needle)

Your Xolair 150 mg pre-filled syringe

After the medicine has been injected the syringe guard will be activated to cover the needle. This is intended to protect against accidental needle stick injuries.

Other items you need for your injection:

  • Alcohol swab.
  • Cotton ball or gauze.
  • Sharps disposal container
  • Adhesive plaster

Important safety information

Caution: Keep the syringe out of the sight and reach of children.

  • The needle cap of the syringe may contain dry rubber (latex), which should not be handled by anyone who is sensitive to this substance.
  • Do not open the sealed outer box until you are ready to use this medicine.
  • Do not use this medicine if either the seal on the outer box or the seal of the plastic tray is broken, as it may not be safe for you to use.
  • Do not use if the syringe has been dropped onto a hard surface or dropped after removing the needle cap.
  • Never leave the syringe where others might tamper with it.
  • Do not shake the syringe.
  • Be careful not to touch the syringe guard wings before use. If the wings are touched, the syringe guard may be activated too early.
  • Do not remove the needle cap until just before you give the injection.
  • The syringe cannot be re-used. Dispose of the used syringe immediately after use in a sharps container.

Storage of the Xolair pre-filled syringe

  • Store this medicine sealed in its outer box to protect it from light. Store in the refrigerator between 2°C and 8°C. DO NOT FREEZE.
  • Prior to use, allow the syringe to reach room temperature (25°C) before preparing it for injection (it will take about 30 minutes). If necessary, the product may be returned to the refrigerator for later use. The total time that the syringe is kept at room temperature must not exceed 48 hours.
  • Do not try to warm the syringe using an external heat source.
  • Do not use the syringe after the expiry date which is stated on the outer box and syringe label. If it has expired, return the entire pack to the pharmacy.

The injection site

The injection site is the place on the body where you are going to use the syringe.

  • The recommended site is the front of the thighs. You may also use the lower abdomen, but not the area 5 centimeters around the navel (belly button).
  • If you need to give more than one injection for the full dose, choose a different injection site each time you inject.
  • If injecting more than once into the same area, ensure a distance of at least 4 cm between injection sites.
  • Do not inject into areas where the skin is tender, bruised, red, or hard. Avoid areas with scars or stretch marks.

If a caregiver is giving the injection, the outer upper arms may also be used.

Preparing the Xolair pre-filled syringe for use

Note: Depending on the dose prescribed to you by your doctor, you may need to prepare one or more pre-filled syringes, and inject the contents of them all.

The following table give EXAMPLES of how many injections of each strength you need for a given dose. Please discuss with your doctor how frequent (4 weekly or 2 weekly) you need to administer each dose

  1. Take the box containing the syringe out of the refrigerator and leave it unopened for about 30 minutes so that it reaches room temperature (leave the syringe in the box to protect it from light).
  2. When you are ready to use the syringe, wash your hands thoroughly with soap and water.
  3. Clean the injection site with an alcohol swab.
  4. Remove the plastic tray from the box and peel back the paper cover. Gripping the middle of the syringe guard, lift the syringe out of the tray.
  5. Inspect the syringe. The liquid should be clear to slightly cloudy. Its colour may vary from colourless to pale brownish-yellow. You may see an air bubble, which is normal. DO NOT USE if the syringe is broken or if the liquid looks distinctly cloudy or distinctly brown, or contains particles. In all these cases, return the entire pack to the pharmacy.
  6. Holding the syringe horizontally, look into the viewing window to check the expiry date printed on the label. (Note: It is possible to rotate the inner part of the syringe assembly so that the label can be read in the viewing window. DO NOT USE if the product has expired. If expired, return the entire pack to the pharmacy.)

How to use the Xolair pre-filled syringe

Carefully remove the needle cap from the syringe. Discard the needle cap. You may see a drop of liquid at the end of the needle. This is normal.

Gently pinch the skin at the injection site and insert the needle as shown. Push the needle all the way in to ensure that the medicine can be fully administered.

Hold the syringe as shown. Slowly depress the plunger as far as it will go so that the plunger head is completely between the syringe guard wings.

Keep the plunger fully depressed while you carefully lift the needle straight out from the injection site.